Global Totally Implantable Intravenous Device (TIVAD) Market Research Report 2023

Report ID: 1668774 | Published Date: Oct 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Totally Implantable Intravenous Device (TIVAD) Market Overview
    1.1 Product Overview and Scope of Totally Implantable Intravenous Device (TIVAD)
    1.2 Totally Implantable Intravenous Device (TIVAD) Segment by Type
        1.2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Titanium Port Body
        1.2.3 Plastic Port Body
    1.3 Totally Implantable Intravenous Device (TIVAD) Segment by Application
        1.3.1 Global Totally Implantable Intravenous Device (TIVAD) Sales Comparison by Application: (2022-2028)
        1.3.2 Cancer
        1.3.3 End-Stage Renal Disease
        1.3.4 Diabetes
    1.4 Global Totally Implantable Intravenous Device (TIVAD) Market Size Estimates and Forecasts
        1.4.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue 2017-2028
        1.4.2 Global Totally Implantable Intravenous Device (TIVAD) Sales 2017-2028
        1.4.3 Totally Implantable Intravenous Device (TIVAD) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Totally Implantable Intravenous Device (TIVAD) Market Competition by Manufacturers
    2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Totally Implantable Intravenous Device (TIVAD) Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Totally Implantable Intravenous Device (TIVAD) Manufacturing Sites, Area Served, Product Type
    2.5 Totally Implantable Intravenous Device (TIVAD) Market Competitive Situation and Trends
        2.5.1 Totally Implantable Intravenous Device (TIVAD) Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Totally Implantable Intravenous Device (TIVAD) Players Market Share by Revenue
        2.5.3 Global Totally Implantable Intravenous Device (TIVAD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Totally Implantable Intravenous Device (TIVAD) Retrospective Market Scenario by Region
    3.1 Global Totally Implantable Intravenous Device (TIVAD) Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Totally Implantable Intravenous Device (TIVAD) Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
        3.3.1 North America Totally Implantable Intravenous Device (TIVAD) Sales by Country
        3.3.2 North America Totally Implantable Intravenous Device (TIVAD) Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
        3.4.1 Europe Totally Implantable Intravenous Device (TIVAD) Sales by Country
        3.4.2 Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Region
        3.5.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Region
        3.5.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
        3.6.1 Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Country
        3.6.2 Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country
        3.7.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Country
        3.7.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Totally Implantable Intravenous Device (TIVAD) Historic Market Analysis by Type
    4.1 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2022)
    4.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2022)
    4.3 Global Totally Implantable Intravenous Device (TIVAD) Price by Type (2017-2022)
5 Global Totally Implantable Intravenous Device (TIVAD) Historic Market Analysis by Application
    5.1 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2022)
    5.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2022)
    5.3 Global Totally Implantable Intravenous Device (TIVAD) Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 C.R. Bard
        6.1.1 C.R. Bard Corporation Information
        6.1.2 C.R. Bard Description and Business Overview
        6.1.3 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.1.5 C.R. Bard Recent Developments/Updates
    6.2 AngioDynamics
        6.2.1 AngioDynamics Corporation Information
        6.2.2 AngioDynamics Description and Business Overview
        6.2.3 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.2.5 AngioDynamics Recent Developments/Updates
    6.3 Smiths Medical
        6.3.1 Smiths Medical Corporation Information
        6.3.2 Smiths Medical Description and Business Overview
        6.3.3 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.3.5 Smiths Medical Recent Developments/Updates
    6.4 Bard Access Systems
        6.4.1 Bard Access Systems Corporation Information
        6.4.2 Bard Access Systems Description and Business Overview
        6.4.3 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.4.5 Bard Access Systems Recent Developments/Updates
    6.5 B. Braun
        6.5.1 B. Braun Corporation Information
        6.5.2 B. Braun Description and Business Overview
        6.5.3 B. Braun Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 B. Braun Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.5.5 B. Braun Recent Developments/Updates
    6.6 Teleflex
        6.6.1 Teleflex Corporation Information
        6.6.2 Teleflex Description and Business Overview
        6.6.3 Teleflex Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Teleflex Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.6.5 Teleflex Recent Developments/Updates
    6.7 Cook Medical
        6.6.1 Cook Medical Corporation Information
        6.6.2 Cook Medical Description and Business Overview
        6.6.3 Cook Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Cook Medical Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.7.5 Cook Medical Recent Developments/Updates
    6.8 Fresenius Kabi
        6.8.1 Fresenius Kabi Corporation Information
        6.8.2 Fresenius Kabi Description and Business Overview
        6.8.3 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.8.5 Fresenius Kabi Recent Developments/Updates
    6.9 PFM Medical
        6.9.1 PFM Medical Corporation Information
        6.9.2 PFM Medical Description and Business Overview
        6.9.3 PFM Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 PFM Medical Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.9.5 PFM Medical Recent Developments/Updates
    6.10 Vygon
        6.10.1 Vygon Corporation Information
        6.10.2 Vygon Description and Business Overview
        6.10.3 Vygon Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Vygon Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.10.5 Vygon Recent Developments/Updates
    6.11 Districlass
        6.11.1 Districlass Corporation Information
        6.11.2 Districlass Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
        6.11.3 Districlass Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Districlass Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.11.5 Districlass Recent Developments/Updates
    6.12 PakuMed
        6.12.1 PakuMed Corporation Information
        6.12.2 PakuMed Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
        6.12.3 PakuMed Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 PakuMed Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.12.5 PakuMed Recent Developments/Updates
    6.13 MedComp
        6.13.1 MedComp Corporation Information
        6.13.2 MedComp Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
        6.13.3 MedComp Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 MedComp Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.13.5 MedComp Recent Developments/Updates
    6.14 Navilyst Medical
        6.14.1 Navilyst Medical Corporation Information
        6.14.2 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
        6.14.3 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.14.5 Navilyst Medical Recent Developments/Updates
    6.15 Norfolk Medical Products
        6.15.1 Norfolk Medical Products Corporation Information
        6.15.2 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
        6.15.3 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.15.5 Norfolk Medical Products Recent Developments/Updates
    6.16 Suzhou Linhwa Medical Devices
        6.16.1 Suzhou Linhwa Medical Devices Corporation Information
        6.16.2 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
        6.16.3 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.16.5 Suzhou Linhwa Medical Devices Recent Developments/Updates
    6.17 Weigao Holding
        6.17.1 Weigao Holding Corporation Information
        6.17.2 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
        6.17.3 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.17.5 Weigao Holding Recent Developments/Updates
    6.18 Guangdong Baihe Medical Technology
        6.18.1 Guangdong Baihe Medical Technology Corporation Information
        6.18.2 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Description and Business Overview
        6.18.3 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Product Portfolio
        6.18.5 Guangdong Baihe Medical Technology Recent Developments/Updates
7 Totally Implantable Intravenous Device (TIVAD) Manufacturing Cost Analysis
    7.1 Totally Implantable Intravenous Device (TIVAD) Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Totally Implantable Intravenous Device (TIVAD)
    7.4 Totally Implantable Intravenous Device (TIVAD) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Totally Implantable Intravenous Device (TIVAD) Distributors List
    8.3 Totally Implantable Intravenous Device (TIVAD) Customers
9 Totally Implantable Intravenous Device (TIVAD) Market Dynamics
    9.1 Totally Implantable Intravenous Device (TIVAD) Industry Trends
    9.2 Totally Implantable Intravenous Device (TIVAD) Market Drivers
    9.3 Totally Implantable Intravenous Device (TIVAD) Market Challenges
    9.4 Totally Implantable Intravenous Device (TIVAD) Market Restraints
10 Global Market Forecast
    10.1 Totally Implantable Intravenous Device (TIVAD) Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Totally Implantable Intravenous Device (TIVAD) by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Totally Implantable Intravenous Device (TIVAD) by Type (2023-2028)
    10.2 Totally Implantable Intravenous Device (TIVAD) Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Totally Implantable Intravenous Device (TIVAD) by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Totally Implantable Intravenous Device (TIVAD) by Application (2023-2028)
    10.3 Totally Implantable Intravenous Device (TIVAD) Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Totally Implantable Intravenous Device (TIVAD) by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Totally Implantable Intravenous Device (TIVAD) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Totally Implantable Intravenous Device (TIVAD) Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Totally Implantable Intravenous Device (TIVAD) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Totally Implantable Intravenous Device (TIVAD) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Totally Implantable Intravenous Device (TIVAD) Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Totally Implantable Intravenous Device (TIVAD) Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Totally Implantable Intravenous Device (TIVAD) Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Totally Implantable Intravenous Device (TIVAD) Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Totally Implantable Intravenous Device (TIVAD) Manufacturing Sites and Area Served
    Table 11. Manufacturers Totally Implantable Intravenous Device (TIVAD) Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Totally Implantable Intravenous Device (TIVAD) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Totally Implantable Intravenous Device (TIVAD) as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Totally Implantable Intravenous Device (TIVAD) Sales by Region (2017-2022) & (K Units)
    Table 16. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Region (2017-2022)
    Table 17. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Region (2017-2022)
    Table 19. North America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2022) & (K Units)
    Table 20. North America Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Country (2017-2022)
    Table 21. North America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Country (2017-2022)
    Table 23. Europe Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Country (2017-2022)
    Table 25. Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Country (2017-2022)
    Table 33. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Country (2017-2022)
    Table 39. Global Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2022) & (K Units)
    Table 40. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2022)
    Table 41. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Type (2017-2022)
    Table 43. Global Totally Implantable Intravenous Device (TIVAD) Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Totally Implantable Intravenous Device (TIVAD) Sales (K Units) by Application (2017-2022)
    Table 45. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2022)
    Table 46. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Application (2017-2022)
    Table 48. Global Totally Implantable Intravenous Device (TIVAD) Price by Application (2017-2022) & (US$/Unit)
    Table 49. C.R. Bard Corporation Information
    Table 50. C.R. Bard Description and Business Overview
    Table 51. C.R. Bard Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. C.R. Bard Totally Implantable Intravenous Device (TIVAD) Product
    Table 53. C.R. Bard Recent Developments/Updates
    Table 54. AngioDynamics Corporation Information
    Table 55. AngioDynamics Description and Business Overview
    Table 56. AngioDynamics Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. AngioDynamics Totally Implantable Intravenous Device (TIVAD) Product
    Table 58. AngioDynamics Recent Developments/Updates
    Table 59. Smiths Medical Corporation Information
    Table 60. Smiths Medical Description and Business Overview
    Table 61. Smiths Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Smiths Medical Totally Implantable Intravenous Device (TIVAD) Product
    Table 63. Smiths Medical Recent Developments/Updates
    Table 64. Bard Access Systems Corporation Information
    Table 65. Bard Access Systems Description and Business Overview
    Table 66. Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Product
    Table 68. Bard Access Systems Recent Developments/Updates
    Table 69. B. Braun Corporation Information
    Table 70. B. Braun Description and Business Overview
    Table 71. B. Braun Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. B. Braun Totally Implantable Intravenous Device (TIVAD) Product
    Table 73. B. Braun Recent Developments/Updates
    Table 74. Teleflex Corporation Information
    Table 75. Teleflex Description and Business Overview
    Table 76. Teleflex Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Teleflex Totally Implantable Intravenous Device (TIVAD) Product
    Table 78. Teleflex Recent Developments/Updates
    Table 79. Cook Medical Corporation Information
    Table 80. Cook Medical Description and Business Overview
    Table 81. Cook Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Cook Medical Totally Implantable Intravenous Device (TIVAD) Product
    Table 83. Cook Medical Recent Developments/Updates
    Table 84. Fresenius Kabi Corporation Information
    Table 85. Fresenius Kabi Description and Business Overview
    Table 86. Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Product
    Table 88. Fresenius Kabi Recent Developments/Updates
    Table 89. PFM Medical Corporation Information
    Table 90. PFM Medical Description and Business Overview
    Table 91. PFM Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. PFM Medical Totally Implantable Intravenous Device (TIVAD) Product
    Table 93. PFM Medical Recent Developments/Updates
    Table 94. Vygon Corporation Information
    Table 95. Vygon Description and Business Overview
    Table 96. Vygon Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Vygon Totally Implantable Intravenous Device (TIVAD) Product
    Table 98. Vygon Recent Developments/Updates
    Table 99. Districlass Corporation Information
    Table 100. Districlass Description and Business Overview
    Table 101. Districlass Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Districlass Totally Implantable Intravenous Device (TIVAD) Product
    Table 103. Districlass Recent Developments/Updates
    Table 104. PakuMed Corporation Information
    Table 105. PakuMed Description and Business Overview
    Table 106. PakuMed Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. PakuMed Totally Implantable Intravenous Device (TIVAD) Product
    Table 108. PakuMed Recent Developments/Updates
    Table 109. MedComp Corporation Information
    Table 110. MedComp Description and Business Overview
    Table 111. MedComp Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. MedComp Totally Implantable Intravenous Device (TIVAD) Product
    Table 113. MedComp Recent Developments/Updates
    Table 114. Navilyst Medical Corporation Information
    Table 115. Navilyst Medical Description and Business Overview
    Table 116. Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Product
    Table 118. Navilyst Medical Recent Developments/Updates
    Table 119. Norfolk Medical Products Corporation Information
    Table 120. Norfolk Medical Products Description and Business Overview
    Table 121. Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Product
    Table 123. Norfolk Medical Products Recent Developments/Updates
    Table 124. Suzhou Linhwa Medical Devices Corporation Information
    Table 125. Suzhou Linhwa Medical Devices Description and Business Overview
    Table 126. Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Product
    Table 128. Suzhou Linhwa Medical Devices Recent Developments/Updates
    Table 129. Weigao Holding Corporation Information
    Table 130. Weigao Holding Description and Business Overview
    Table 131. Weigao Holding Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Weigao Holding Totally Implantable Intravenous Device (TIVAD) Product
    Table 133. Weigao Holding Recent Developments/Updates
    Table 134. Guangdong Baihe Medical Technology Corporation Information
    Table 135. Guangdong Baihe Medical Technology Description and Business Overview
    Table 136. Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Product
    Table 138. Guangdong Baihe Medical Technology Recent Developments/Updates
    Table 139. Production Base and Market Concentration Rate of Raw Material
    Table 140. Key Suppliers of Raw Materials
    Table 141. Totally Implantable Intravenous Device (TIVAD) Distributors List
    Table 142. Totally Implantable Intravenous Device (TIVAD) Customers List
    Table 143. Totally Implantable Intravenous Device (TIVAD) Market Trends
    Table 144. Totally Implantable Intravenous Device (TIVAD) Market Drivers
    Table 145. Totally Implantable Intravenous Device (TIVAD) Market Challenges
    Table 146. Totally Implantable Intravenous Device (TIVAD) Market Restraints
    Table 147. Global Totally Implantable Intravenous Device (TIVAD) Sales Forecast by Type (2023-2028) & (K Units)
    Table 148. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share Forecast by Type (2023-2028)
    Table 149. Global Totally Implantable Intravenous Device (TIVAD) Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 150. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share Forecast by Type (2023-2028)
    Table 151. Global Totally Implantable Intravenous Device (TIVAD) Sales Forecast by Application (2023-2028) & (K Units)
    Table 152. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share Forecast by Application (2023-2028)
    Table 153. Global Totally Implantable Intravenous Device (TIVAD) Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 154. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share Forecast by Application (2023-2028)
    Table 155. Global Totally Implantable Intravenous Device (TIVAD) Sales Forecast by Region (2023-2028) & (K Units)
    Table 156. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share Forecast by Region (2023-2028)
    Table 157. Global Totally Implantable Intravenous Device (TIVAD) Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 158. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share Forecast by Region (2023-2028)
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Totally Implantable Intravenous Device (TIVAD)
    Figure 2. Global Totally Implantable Intravenous Device (TIVAD) Market Share by Type in 2021 & 2028
    Figure 3. Titanium Port Body Product Picture
    Figure 4. Plastic Port Body Product Picture
    Figure 5. Global Totally Implantable Intravenous Device (TIVAD) Market Share by Application in 2021 & 2028
    Figure 6. Cancer
    Figure 7. End-Stage Renal Disease
    Figure 8. Diabetes
    Figure 9. Global Totally Implantable Intravenous Device (TIVAD) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Totally Implantable Intravenous Device (TIVAD) Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Totally Implantable Intravenous Device (TIVAD) Sales (2017-2028) & (K Units)
    Figure 12. Totally Implantable Intravenous Device (TIVAD) Sales Share by Manufacturers in 2021
    Figure 13. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Totally Implantable Intravenous Device (TIVAD) Players: Market Share by Revenue in 2021
    Figure 15. Totally Implantable Intravenous Device (TIVAD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Region (2017-2022)
    Figure 17. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Region in 2021
    Figure 18. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Region (2017-2022)
    Figure 19. Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Region in 2021
    Figure 20. United States Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Colombia Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE Totally Implantable Intravenous Device (TIVAD) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Totally Implantable Intravenous Device (TIVAD) by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of Totally Implantable Intravenous Device (TIVAD)
    Figure 45. Manufacturing Process Analysis of Totally Implantable Intravenous Device (TIVAD)
    Figure 46. Totally Implantable Intravenous Device (TIVAD) Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
C.R. Bard
AngioDynamics
Smiths Medical
Bard Access Systems
B. Braun
Teleflex
Cook Medical
Fresenius Kabi
PFM Medical
Vygon
Districlass
PakuMed
MedComp
Navilyst Medical
Norfolk Medical Products
Suzhou Linhwa Medical Devices
Weigao Holding
Guangdong Baihe Medical Technology
Frequently Asked Questions
Totally Implantable Intravenous Device (TIVAD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Totally Implantable Intravenous Device (TIVAD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Totally Implantable Intravenous Device (TIVAD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports